1. Stalls, V., Lindenberger, J., Gobeil, S. M. C., Henderson, R., Parks, R., Barr, M., Deyton, M., Martin, M., Janowska, K., Huang, X., May, A., Speakman, M., Beaudoin, E., Edwards, R.J., Eaton, A., Montefiori, D.C., Williams, W., Saunders, K.O., Wiehe, K., Haynes, B.F., Acharya P. (2022) Cryo-EM structures of SARS-CoV-2 Omicron BA.2 Spike. BioRxiv 2022.04.07.487528; doi:

2. *indicates co-first authorship: Gobeil, S.M.C.*, Henderson, R.*, Stalls, V.*, Janowska, K., Huang, X., May, A., Speakman, M., Beaudoin, E., Manne, K., Li, D., Parks, R., Barr, M., Deyton, M., Martin, M., Mansouri, K., Edwards, R.J., Sempowski, G.D., Saunders, K.O., Wiehe, K., Williams, W., Korber, B., Haynes, B.F., Acharya, P. (2022) Structural diversity of the SARS-CoV-2 Omicron spike, Mol. Cell. 82, 2050-2068.e6

3. Gobeil, S. M. C., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Stalls, V., Kopp, M. F., Manne, K., Li, D., Wiehe, K., Saunders, K. O., Edwards, R. J., Korber, B., Haynes, B. F., Henderson, R. & Acharya, P. (2021) Effect of natural mutations of SARS-CoV-2 on spike structure, conformation, and antigenicity, Science. 373.

4. * indicates co-first authorship: Martinez, D. R.*, Schafer, A.*, Gobeil, S.M.C.*, Li, D.*, De la Cruz, G., Parks, R., Lu, X., Barr, M., Stalls, V., Janowska, K., Beaudoin, E., Manne, K., Mansouri, K., Edwards, R. J., Cronin, K., Yount, B., Anasti, K., Montgomery, S. A., Tang, J., Golding, H., Shen, S., Zhou, T., Kwong, P. D., Graham, B. S., Mascola, J. R., Montefiori, D. C., Alam, S. M., Sempowski, G. D., Khurana, S., Wiehe, K., Saunders, K. O., Acharya, P., Haynes, B. F. & Baric, R. S. (2021) A broadly cross-reactive antibody neutralizes and protects against sarbecovirus challenge in mice, Science Translational Medicine, eabj7125.

5. Gobeil, S. M. C., Janowska, K., McDowell, S., Mansouri, K., Parks, R., Manne, K., Stalls, V., Kopp, M. F., Henderson, R., Edwards, R. J., Haynes, B. F. & Acharya, P. (2021) D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction, Cell Reports. 34.

6. Gobeil, S. M. C., Bobay, B. G., Juvvadi, P. R., Cole, D. C., Heitman, J., Steinbach, W. J., Venters, R. A. & Spicer, L. D. (2021) Leveraging Fungal and Human Calcineurin-Inhibitor Structures, Biophysical Data, and Dynamics to Design Selective and Nonimmunosuppressive FK506 Analogs, mBio. 12, e03000-21.

7. Saunders, K. O., Lee, E., Parks, R., Martinez, D. R., Li, D., Chen, H., Edwards, R. J., Gobeil, S.M.C, Barr, M., Mansouri, K., Alam, S. M., Sutherland, L. L., Cai, F., Sanzone, A. M., Berry, M., Manne, K., Bock, K. W., Minai, M., Nagata, B. M., Kapingidza, A. B., Azoitei, M., Tse, L. V., Scobey, T. D., Spreng, R. L., Rountree, R. W., DeMarco, C. T., Denny, T. N., Woods, C. W., Petzold, E. W., Tang, J., Oguin, T. H., Sempowski, G. D., Gagne, M., Douek, D. C., Tomai, M. A., Fox, C. B., Seder, R., Wiehe, K., Weissman, D., Pardi, N., Golding, H., Khurana, S., Acharya, P., Andersen, H., Lewis, M. G., Moore, I. N., Montefiori, D. C., Baric, R. S. & Haynes, B. F. (2021) Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses, Nature. 594, 553- 559.

8. Williams, W. B., Meyerhoff, R. R., Edwards, R. J., Li, H., Manne, K., Nicely, N. I., Henderson, R., Zhou, Y., Janowska, K., Mansouri, K., Gobeil, S.M.C, Evangelous, T., Hora, B., Berry, M., Abuahmad, A. Y., Sprenz, J., Deyton, M., Stalls, V., Kopp, M., Hsu, A. L., Borgnia, M. J., Stewart- Jones, G. B. E., Lee, M. S., Bronkema, N., Moody, M. A., Wiehe, K., Bradley, T., Alam, S. M., Parks, R. J., Foulger, A., Oguin, T., Sempowski, G. D., Bonsignori, M., LaBranche, C. C., Montefiori, D. C., Seaman, M., Santra, S., Perfect, J., Francica, J. R., Lynn, G. M., Aussedat, B.,Walkowicz, W. E., Laga, R., Kelsoe, G., Saunders, K. O., Fera, D., Kwong, P. D., Seder, R. A., Bartesaghi, A., Shaw, G. M., Acharya, P. & Haynes, B. F. (2021) Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies, Cell. 184, 2955-2972.e25.

9. Li, D., Edwards, R. J., Manne, K., Martinez, D. R., Schäfer, A., Alam, S. M., Wiehe, K., Lu, X., Parks, R., Sutherland, L. L., Oguin, T. H., McDanal, C., Perez, L. G., Mansouri, K., Gobeil, S. M. C., Janowska, K., Stalls, V., Kopp, M., Cai, F., Lee, E., Foulger, A., Hernandez, G. E., Sanzone, A., Tilahun, K., Jiang, C., Tse, L. V., Bock, K. W., Minai, M., Nagata, B. M., Cronin, K., Gee-Lai, V., Deyton, M., Barr, M., Von Holle, T., Macintyre, A. N., Stover, E., Feldman, J., Hauser, B. M., Caradonna, T. M., Scobey, T. D., Rountree, W., Wang, Y., Moody, M. A., Cain, D. W., DeMarco, C. T., Denny, T. N., Woods, C. W., Petzold, E. W., Schmidt, A. G., Teng, I. T., Zhou, T., Kwong, P. D., Mascola, J. R., Graham, B. S., Moore, I. N., Seder, R., Andersen, H., Lewis, M. G., Montefiori, D. C., Sempowski, G. D., Baric, R. S., Acharya, P., Haynes, B. F. & Saunders, K. O. (2021) Invitro and invivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies, Cell. 184, 4203-4219.e32.

10. *indicates co-first authorship: Edwards, R. J.*, Mansouri, K.*, Stalls, V.*, Manne, K.*, Watts, B., Parks, R., Janowska, K., Gobeil, S. M. C., Kopp, M., Li, D., Lu, X., Mu, Z., Deyton, M., Oguin, T. H., Sprenz, J., Williams, W., Saunders, K. O., Montefiori, D., Sempowski, G. D., Henderson, R., Munir Alam, S., Haynes, B. F. & Acharya, P. (2021) Cold sensitivity of the SARS-CoV-2 spike ectodomain, Nature Structural & Molecular Biology. 28, 128-131.

11. Weissman, D., Alameh, M.-G., de Silva, T., Collini, P., Hornsby, H., Brown, R., LaBranche, C. C., Edwards, R. J., Sutherland, L., Santra, S., Mansouri, K., Gobeil, S.M.C, McDanal, C., Pardi, N., Hengartner, N., Lin, P. J. C., Tam, Y., Shaw, P. A., Lewis, M. G., Boesler, C., Şahin, U., Acharya, P., Haynes, B. F., Korber, B. & Montefiori, D. C. (2021) D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization, Cell Host & Microbe. 29, 23-31.e4.

12. Paquet-Côté, P.-A., Alejaldre, L., Lapointe Verreault, C., Gobeil, S. M. C., Lamoureux, R., Bédard, L., Normandeau, C.-O., Lemay-St-Denis, C., Pelletier, J. N. & Voyer, N. (2021) Development of sulfahydantoin derivatives as β-lactamase inhibitors, Bioorganic & Medicinal Chemistry Letters. 35.

13. Henderson, R., Edwards, R. J., Mansouri, K., Janowska, K., Stalls, V., Gobeil, S. M. C., Kopp, M., Li, D., Parks, R., Hsu, A. L., Borgnia, M. J., Haynes, B. F. & Acharya, P. (2020) Controlling the SARS-CoV-2 spike glycoprotein conformation, Nature Structural & Molecular Biology. 27, 925- 933.

14. Juvvadi, P. R., Bobay, B. G., Gobeil, S. M. C., Cole, D. C., Venters, R. A., Heitman, J., Spicer, L. D. & Steinbach, W. J. (2020) FKBP12 dimerization mutations effect FK506 binding and differentially alter calcineurin inhibition in the human pathogen Aspergillus fumigatus, Biochemical and Biophysical Research Communications. 526, 48-54.

15. Juvvadi, P. R., Fox, D., Bobay, B. G., Hoy, M. J., Gobeil, S. M. C., Venters, R. A., Chang, Z., Lin, J. J., Averette, A. F., Cole, D. C., Barrington, B. C., Wheaton, J. D., Ciofani, M., Trzoss, M., Li, X., Lee, S. C., Chen, Y.-L., Mutz, M., Spicer, L. D., Schumacher, M. A., Heitman, J. & Steinbach, W. J. (2019) Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents, Nature Communications. 10.

16. Gobeil, S. M. C., Bobay, B. G., Spicer, L. D. & Venters, R. A. (2019) 15N, 13C and 1H resonance assignments of FKBP12 proteins from the pathogenic fungi Mucor circinelloides and Aspergillusfumigatus, Biomolecular NMR Assignments. 13, 207-212.

17. Gobeil, S. M. C., Ebert, M. C. C. J. C., Park, J., Gagné, D., Doucet, N., Berghuis, A. M., Pleiss, J. & Pelletier, J. N. (2019) The Structural Dynamics of Engineered β-Lactamases Vary Broadly on Three Timescales yet Sustain Native Function, Scientific Reports. 9.

18. Gobeil, S. M. C., Gagné, D., Doucet, N. & Pelletier, J. N. (2016) 15N, 13C and 1H backbone resonance assignments of an artificially engineered TEM-1/PSE-4 class A β-lactamase chimera and its deconvoluted mutant, Biomolecular NMR Assignments. 10, 93-99.

19. Gobeil SMC, Clouthier CM, Park J, Gagne D, Berghuis AM, Doucet N and Pelletier JN. Maintenance of Native- like Protein Dynamics Many Not Be Required for Engineering Functional Proteins. Chemistry and Biology. 2014; 21(10): 1330-40.

20. Clouthier CM, Morin S, Gobeil SMC, Doucet N, Blanchet J, Nguyen E, Gagne SM and Pelletier JN. Chimeric β- Lactamases: Global Conservation of Parental Function and Fast Time-scale Dynamics with Increased Slow Motions. PLoS One. 2012; 7(12): e52283.

21. Morin S, Clouthier C, Gobeil SMC, Pelletier JN and Gagne SM. Backbone Resonance Assignments of an Artificially Engineered TEM1/PSE4 Class A β-Lactamase Chimera, Biomolecular NMR Assignments. 2010; 4(2): 127-30.


Institut de Biologie Intégrative et des Systèmes (IBIS)
Pavillon Charles-Eugène-Marchand
Université Laval
1030, Avenue de la Médecine
Québec (Québec), G1V 0A6


Phone: +1 (418) 656 2131
Fax: +1 (418) 948 5487